tiprankstipranks
Advertisement
Advertisement

HK:1244 Stock Latest News

3D Medicines Sets 2026 AGM to Approve Results, Board Changes and Share Mandate
Company Announcements3D Medicines Sets 2026 AGM to Approve Results, Board Changes and Share Mandate
13d ago
1244
3D Medicines’ Envafolimab Trial in Biliary Tract Cancer to Headline 2026 ASCO Meeting
PremiumCompany Announcements
3D Medicines’ Envafolimab Trial in Biliary Tract Cancer to Headline 2026 ASCO Meeting
23d ago
1244
3D Medicines Completes Phase III Envafolimab Lung Cancer Trial Enrollment Ahead of Schedule
PremiumCompany Announcements
3D Medicines Completes Phase III Envafolimab Lung Cancer Trial Enrollment Ahead of Schedule
28d ago
1244
3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
PremiumCompany Announcements
3D Medicines Extends HK$50 Million Note to Puxin, Flags Disclosure Lapse
3M ago
1244
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
PremiumCompany Announcements
3D Medicines Advances Oncology Platforms Despite Envafolimab Revenue Dip in 2025
3M ago
1244
3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
PremiumCompany Announcements3D Medicines Sets March 31 Board Meeting to Approve 2025 Results and Mull Dividend
3M ago
1244
3D Medicines Moves Envafolimab Toward Full Approval in China
Premium
Company Announcements
3D Medicines Moves Envafolimab Toward Full Approval in China
4M ago
1244
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
Premium
Company Announcements
3D Medicines Appoints Veteran Capital Markets Executive as New CFO
5M ago
1244
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
PremiumCompany Announcements
3D Medicines’ Envafolimab NDA for First-Line Biliary Tract Cancer Accepted by China’s NMPA
5M ago
1244
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
PremiumCompany Announcements
3D Medicines Wins Third Orphan-Drug Designation for Envafolimab in Gastric Cancers
6M ago
1244
3D Medicines’ New Cancer Pain Study: Potential Market Impact
PremiumCompany Announcements
3D Medicines’ New Cancer Pain Study: Potential Market Impact
8M ago
1244
3D Medicines Reports Strong Progress and Global Expansion in H1 2025
PremiumCompany Announcements
3D Medicines Reports Strong Progress and Global Expansion in H1 2025
10M ago
1244
3D Medicines Administers First Dose of Novel Cancer Drug
PremiumCompany Announcements3D Medicines Administers First Dose of Novel Cancer Drug
10M ago
1244
3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy Development
Premium
Company Announcements
3D Medicines Partners with CATUG Biotechnology to Enhance mRNA Therapy Development
10M ago
1244
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration
Premium
Company Announcements
3D Medicines Inc. Schedules Board Meeting for Interim Results and Dividend Consideration
10M ago
1244
3D Medicines Inc. Announces Withdrawal of Legal Proceedings
PremiumCompany Announcements
3D Medicines Inc. Announces Withdrawal of Legal Proceedings
11M ago
1244
3D Medicines Inc. Strengthens Stability with Strategic Agreement
PremiumCompany Announcements
3D Medicines Inc. Strengthens Stability with Strategic Agreement
11M ago
1244
3D Medicines, Inc. Enhances Operational Stability Through Strategic Cooperation
PremiumCompany Announcements
3D Medicines, Inc. Enhances Operational Stability Through Strategic Cooperation
12M ago
1244
3D Medicines Inc. Announces Successful AGM Resolutions
PremiumCompany Announcements
3D Medicines Inc. Announces Successful AGM Resolutions
12M ago
1244
3D Medicines Inc. Announces Board Composition and Committee Assignments
PremiumCompany Announcements3D Medicines Inc. Announces Board Composition and Committee Assignments
12M ago
1244
3D Medicines Inc. Announces Board Changes with New Non-Executive Director Appointment
Premium
Company Announcements
3D Medicines Inc. Announces Board Changes with New Non-Executive Director Appointment
1y ago
1244
3D Medicines Inc. Announces Annual General Meeting to Discuss Key Resolutions
Premium
Company Announcements
3D Medicines Inc. Announces Annual General Meeting to Discuss Key Resolutions
1y ago
1244

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >